“…The targeting of b-catenin for degradation involves the phosphorylation of its N-terminus by glycogen synthase kinase 3b (GSK) (Aberle et al, 1997;Yost et al, 1996) which occurs in a multi-protein complex consisting of b-catenin, GSK, the adenoma-tous polyposis coli (APC) tumor suppressor protein and axin/conductin Rubinfeld et al, 1996;Zeng et al, 1997;Ikeda et al, 1998;Behrens et al, 1998;Yamamoto et al, 1998). This complex associates with the ubiquitin ligase, b-TrCP (b-transducin repeat-containing protein) that recognizes the N-terminally phosphorylated forms of bcatenin and regulates its ubiquitination and degradation by the proteasome (Winston et al, 1999;Liu et al, 1999;Latres et al, 1999;Hart et al, 1999;Kitagawa et al, 1999). b-TrCP associates through its F-box with Cul1/Skp1/ROC1 forming the modular ubiquitin ligase SCF complex (Latres et al, 1999;Tan et al, 1999) and via its WD repeat motif with the phosphorylated bcatenin (Winston et al, 1999;Liu et al, 1999;Hart et al, 1999), thus forming a multimolecular complex consisting of b-TrCP/b-catenin/Axin/GSK/APC (Liu et al, 1999;Kitagawa et al, 1999).…”